A detailed history of Adar1 Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 44,635 shares of IKNA stock, worth $69,184. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,635
Previous 46,685 4.39%
Holding current value
$69,184
Previous $77 Million 0.25%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.6 - $1.85 $3,280 - $3,792
-2,050 Reduced 4.39%
44,635 $77.2 Million
Q2 2024

Aug 13, 2024

BUY
$1.24 - $1.82 $14,489 - $21,266
11,685 Added 33.39%
46,685 $77 Million
Q1 2024

May 15, 2024

BUY
$1.27 - $2.0 $44,450 - $70,000
35,000 New
35,000 $49.7 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $56.2M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.